US Food and Drug Administration (USFDA) has completed inspection of Ajanta Pharma’s formulation facility at Dahej in the state of Gujarat from July 23-27, 2018. After the inspection, there were no observations found.
Ajanta Pharma is a speciality pharmaceutical formulation company having branded generic business in India and emerging markets, generic business in US and institution business in Africa.